Engeletin inhibits Lipopolysaccharide/d-galactosamine-induced liver injury in mice through activating PPAR-γ

• Principais autores: Qing Tian (Autor), Guijie Wang (Autor), Yamin Zhang (Autor), Fubo Zhang (Autor), Long Yang (Autor), Zirong Liu (Autor), Zhongyang Shen (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2019-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Liver injury is a serious clinical syndrome that characterized by inflammatory response. Engeletin is known to have anti-inflammatory activity. However, the effects of engeletin on liver injury remain unclear. We aimed to assess the protective effect of engeletin on Lipopolysaccharide (LPS)/d-galact...